McMaster University

McMaster University

Faculty of
Health Sciences

McMaster scientist responds to announcement on HIV Vaccine funding

Published: February 20, 2007
Ken Rosenthal
Ken Rosenthal, professor and head of the viral vaccines division of the Centre for Gene Therapeutics at McMaster University’s Michael G. DeGroote School of Medicine

Ken Rosenthal, professor and head of the viral vaccines division of the Centre for Gene Therapeutics at McMaster University’s Michael G. DeGroote School of Medicine, attended an announcement today in Ottawa by Prime Minister Stephen Harper and billionaire philanthropist Bill Gates about a multimillion-dollar initiative to combat HIV, the virus that causes AIDS.

The Harper government is committing up to $111 million to a new fund called the Canadian HIV Vaccine Initiative, and the Bill and Melinda Gates Foundation has pledged up to $28 million.

Rosenthal is currently looking at developing a variety of delivery systems for the vaccines, including novel mucosal vaccines based on molecules that activate the innate immune system.  Listen to his response about the new initiative on Ontario Today:

Ontario Today - HIV Vaccines

[BACK] [TOP]
Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0